Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 112

1.

Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort.

Perna L, Zhang Y, Mons U, Holleczek B, Saum KU, Brenner H.

Clin Epigenetics. 2016 Jun 3;8:64. doi: 10.1186/s13148-016-0228-z. eCollection 2016.

2.

Comparison of prostate cancer survival in Germany and the United States: Can differences be attributed to differences in stage distributions?

Winter A, Sirri E, Jansen L, Wawroschek F, Kieschke J, Castro FA, Krilaviciute A, Holleczek B, Emrich K, Waldmann A, Brenner H; GEKID Cancer Survival Working Group.

BJU Int. 2016 May 21. doi: 10.1111/bju.13537. [Epub ahead of print]

PMID:
27208546
3.

Histologic types of gastric cancer among migrants from the former Soviet Union and the general population in Germany: what kind of prevention do we need?

Jaehn P, Holleczek B, Becher H, Winkler V.

Eur J Gastroenterol Hepatol. 2016 Aug;28(8):863-70. doi: 10.1097/MEG.0000000000000645.

PMID:
27187801
4.

Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation.

Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H; GEKID Cancer Survival Working Group and the DRST.

Eur J Cancer. 2016 Jul;62:1-8. doi: 10.1016/j.ejca.2016.04.004. Epub 2016 May 10.

PMID:
27185572
5.

Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults.

Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H; GEKID Cancer Survival Working Group.

Int J Cancer. 2016 Sep 15;139(6):1289-96. doi: 10.1002/ijc.30186. Epub 2016 May 31.

PMID:
27176899
6.

Fear of Recurrence in Long-Term Cancer Survivors-Do Cancer Type, Sex, Time Since Diagnosis, and Social Support Matter?

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V.

Health Psychol. 2016 May 12. [Epub ahead of print]

PMID:
27175578
7.

Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.

Werner S, Chen H, Butt J, Michel A, Knebel P, Holleczek B, Zörnig I, Eichmüller SB, Jäger D, Pawlita M, Waterboer T, Brenner H.

Sci Rep. 2016 May 3;6:25467. doi: 10.1038/srep25467.

8.

Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century.

Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H; GEKID Cancer Survival Working Group.

J Hematol Oncol. 2016 Mar 22;9:28. doi: 10.1186/s13045-016-0257-2.

9.

Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study.

Chen XZ, Schöttker B, Castro FA, Chen H, Zhang Y, Holleczek B, Brenner H.

Oncotarget. 2016 Mar 29;7(13):17182-93. doi: 10.18632/oncotarget.7946.

10.

Declining Bowel Cancer Incidence and Mortality in Germany.

Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M.

Dtsch Arztebl Int. 2016 Feb 19;113(7):101-6. doi: 10.3238/arztebl.2016.0101.

11.

Frailty is associated with the epigenetic clock but not with telomere length in a German cohort.

Breitling LP, Saum KU, Perna L, Schöttker B, Holleczek B, Brenner H.

Clin Epigenetics. 2016 Feb 26;8:21. doi: 10.1186/s13148-016-0186-5. eCollection 2016.

12.

Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.

Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K; GEKID Cancer Survival Working Group.

Sci Rep. 2016 Feb 24;6:22084. doi: 10.1038/srep22084.

13.

Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States.

Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H.

Pancreas. 2016 Jul;45(6):908-14. doi: 10.1097/MPA.0000000000000588.

PMID:
26745860
14.

Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time.

Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L; GEKID Cancer Survival Workgroup.

Eur J Cancer. 2016 Jan;52:102-8. doi: 10.1016/j.ejca.2015.10.059. Epub 2015 Dec 9.

PMID:
26682869
15.
16.

Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data.

Schöttker B, Brenner H, Jansen EH, Gardiner J, Peasey A, Kubínová R, Pająk A, Topor-Madry R, Tamosiunas A, Saum KU, Holleczek B, Pikhart H, Bobak M.

BMC Med. 2015 Dec 15;13:300. doi: 10.1186/s12916-015-0537-7.

17.

Body mass index and leukocyte telomere length dynamics among older adults: Results from the ESTHER cohort.

Müezzinler A, Mons U, Dieffenbach AK, Butterbach K, Saum KU, Schick M, Stammer H, Boukamp P, Holleczek B, Stegmaier C, Brenner H.

Exp Gerontol. 2016 Feb;74:1-8. doi: 10.1016/j.exger.2015.11.019. Epub 2015 Nov 30.

PMID:
26657493
18.

Associations of metabolic, inflammatory and oxidative stress markers with total morbidity and multi-morbidity in a large cohort of older German adults.

Schöttker B, Saum KU, Jansen EH, Holleczek B, Brenner H.

Age Ageing. 2016 Jan;45(1):127-35. doi: 10.1093/ageing/afv159. Epub 2015 Nov 11.

PMID:
26563887
19.

Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients.

Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H; GEKID Survival Working Group.

Lung Cancer. 2015 Dec;90(3):528-33. doi: 10.1016/j.lungcan.2015.10.007. Epub 2015 Oct 20.

PMID:
26480866
20.

Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study.

Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M, Dimitrova N, Innos K, Katalinic A, Langseth H, Larrañaga N, Rossi S, Siesling S, Minicozzi P; EUROCARE-5 Working Group.

Eur J Cancer. 2015 Sep 6. pii: S0959-8049(15)00702-9. doi: 10.1016/j.ejca.2015.07.022. [Epub ahead of print]

PMID:
26421822
Items per page

Supplemental Content

Loading ...
Write to the Help Desk